Commonwealth Equity Services’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,082
Closed -$10K 4029
2023
Q4
$10K Buy
4,082
+500
+14% +$1.09K ﹤0.01% 3857
2023
Q3
$8K Buy
3,582
+200
+6% +$719 ﹤0.01% 3788
2023
Q2
$18K Sell
3,382
-190
-5% -$1.22K ﹤0.01% 3755
2023
Q1
$22K Buy
3,572
+50
+1% +$402 ﹤0.01% 3660
2022
Q4
$45K Sell
3,522
-1,379
-28% -$25.4K ﹤0.01% 3525
2022
Q3
$113K Sell
4,901
-80
-2% -$2.43K ﹤0.01% 3347
2022
Q2
$169K Buy
+4,981
New +$405K ﹤0.01% 3255

Other funds holding CELU

Commonwealth Equity Services's CELU Position: Q1 2024 in Review

Commonwealth Equity Services sold out of Celularity (CELU) in Q1 2024, closing a stake of 4,082 shares — an estimated $10K sold.

Commonwealth Equity Services first reported a position in CELU in Q2 2022 and held it in 7 quarters. The position peaked at $169K in Q2 2022. 30 funds tracked by Wall St. Rank hold CELU as of Q1 2024.

  • Commonwealth Equity Services reported no remaining Celularity position as of Q1 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 4,082 Celularity shares in Q1 2024, an estimated $10K.
  • Commonwealth Equity Services first reported a position in Celularity in Q2 2022 and held it in 7 quarters.
  • Commonwealth Equity Services's Celularity position peaked at $169K in Q2 2022.
  • 30 funds tracked by Wall St. Rank held Celularity as of Q1 2024.

Based on Commonwealth Equity Services's 13F filing for Q1 2024, filed 29 Apr 2024.